In the news | 1st March 2022
Advances in Biologics Require Advances in Data Management
Throughout the past few years, there’s been a clear trend in the makeup of approvals, with biologics representing a growing percentage. But even within biologics, newer technologies like mRNA, cell, and gene therapies are gaining ground. The approvals are not one-off events, but evidence of an exciting long-term trend. Learn more from Christian Marcazzo, General Manager at IDBS, in his article published in Drug Development & Discovery.
A new blueprint for technology transfer
Technology transfer is a necessary evil that exists between drug development and manufacturing. But information sharing is disjointed.
Tradeshow | Paperless Lab Academy 2023 India, October 10-11, 2023
Come and see us at Paperless Lab Academy 2023 India. Visit our booth G8 and attend our workshop on “Managing R&D data for faster and efficient workflows with IDBS Polar platform”.
Tradeshow | Festival of Biologics | October 2023
Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Tradeshow | Biologics Contract Manufacturing Asia | September, 2023
Learn how to overcome manufacturing data challenges with IDBS at this year’s event in Singapore. We look forward to seeing you there!